Alto Neuroscience, Inc. Statistics
Want to see ANRO full AI Analyst Report?
Alto Neuroscience, Inc. (ANRO) Stock Statistics & Valuation Metrics
Total Valuation
Alto Neuroscience, Inc. has a market cap or net worth of $1.12B. The enterprise value is $886.61M.
- Market Cap
- $1.12B
- Enterprise Value
- $886.61M
Share Statistics
Alto Neuroscience, Inc. has 39,242,104 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 39,242,104
- Owned by Insiders
- 4.17%
- Owned by Institutions
- 20.61%
Financial Efficiency
Alto Neuroscience, Inc.’s return on equity (ROE) is -0.42 and return on invested capital (ROIC) is -38.15%.
- Return on Equity (ROE)
- -0.42
- Return on Assets (ROA)
- -0.34
- Return on Invested Capital (ROIC)
- -38.15%
- Return on Capital Employed (ROCE)
- -0.38
- Revenue Per Employee
- 0
- Profits Per Employee
- -929.97K
- Employee Count
- 68
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Alto Neuroscience, Inc. is -11.44. Alto Neuroscience, Inc.’s PEG ratio is 1.20.
- PE Ratio
- -11.44
- PS Ratio
- 0.00
- PB Ratio
- 4.49
- Price to FCF
- -16.31
- Price to Operating Cash Flow
- -19.50
- PEG Ratio
- 1.20
Income Statement
In the last 12 months, Alto Neuroscience, Inc. had revenue of 0 and earned -63.24M in profits. Earnings per share was -2.19.
- Revenue
- 0
- Gross Profit
- -661.00K
- Operating Income
- -66.36M
- Pretax Income
- -63.24M
- Net Income
- -63.24M
- EBITDA
- -60.11M
- Earnings Per Share (EPS)
- -2.19
Cash Flow
In the last 12 months, operating cash flow was -68.28M and capital expenditures -556,000, giving a free cash flow of -68.84M billion.
- Operating Cash Flow
- -68.28M
- Free Cash Flow
- -68.84M
- Free Cash Flow per Share
- -1.48
Dividends & Yields
Alto Neuroscience, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -6.27%
- Earnings Yield
- -7.03%
Stock Price Statistics
- Beta
- 1.57
- 52-Week Price Change
- 124.57%
- 50-Day Moving Average
- 26.99
- 200-Day Moving Average
- 24.57
- Relative Strength Index (RSI)
- 65.40
- Average Volume (3m)
- 581.99K
Important Dates
Alto Neuroscience, Inc. upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 10, 2026
- Next Earnings Date
- Mar 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Alto Neuroscience, Inc. as a current ratio of 15.69, with Debt / Equity ratio of 2.92%
- Current Ratio
- 15.69
- Quick Ratio
- 15.69
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 2.86
- Interest Coverage Ratio
- -26.88
Taxes
In the past 12 months, Alto Neuroscience, Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Alto Neuroscience, Inc. EV to EBITDA ratio is -10.60, with an EV/FCF ratio of -12.51.
- EV to Sales
- 0.00
- EV to EBITDA
- -10.60
- EV to Free Cash Flow
- -12.51
- EV to Operating Cash Flow
- -12.61
Balance Sheet
Alto Neuroscience, Inc. has $243.73M in cash and marketable securities with $7.05M in debt, giving a net cash position of $236.68M billion.
- Cash & Marketable Securities
- $243.73M
- Total Debt
- $7.05M
- Net Cash
- $236.68M
- Net Cash Per Share
- $6.03
- Tangible Book Value Per Share
- $5.12
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Alto Neuroscience, Inc. is $45.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $45.67
- Price Target Upside
- 59.62% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 5
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -3.04%
Scores
- Smart Score
- 6
- AI Score
- 45
